The most consistent epigenetic controller of ERK is miR-20a, which down-regulates ERK-induced Pgp transcription in breast cancer cells [131] and restores chemosensitivity in osteosarcoma cells [132]. The gene discussed is MAPK1; the disease is osteosarcoma.